Literature DB >> 34049506

Application value of tissue tuberculosis antigen combined with Xpert MTB/RIF detection in differential diagnoses of intestinal tuberculosis and Crohn's disease.

Baoying Fei1, Lin Zhou2, Yu Zhang3, Linhe Luo4, Yuanyuan Chen5.   

Abstract

BACKGROUND: The purpose of this study was to examine the value of Xpert MTB/RIF assay and detection of additional Mycobacterium tuberculosis complex (MTBC) species antigens from intestinal tissue samples in differentiating intestinal tuberculosis (ITB) from Crohn's disease (CD).
METHODS: Several clinical specimens of intestinal tissue obtained by either endoscopic biopsy or surgical excision were used for mycobacteriologic solid cultures,Xpert MTB/RIF assays, immunohistochemistry, and histological examinations. Four antigens (38KDa, ESAT-6, MPT64, and Ag85 complex) of MTBC in the intestinal tissue were detected by immunohistochemical analysis.
RESULTS: The study included 42 patients with ITB and 46 with CD. Perianal lesions and longitudinal ulcers were more common in patients with CD, while caseating granuloma and annular ulcers were more common in patients with ITB. The positive rate of MTBC detected by Xpert MTB/RIF in intestinal tissues of patients with ITB was 33.33%, which was significantly higher than that in patients with CD and that detected using acid-fast staining smears. It was also higher than that detected by tissue MTBC culture, but the difference was not statistically significant. The positive MPT64 expression rate in patients with ITB was 40.48%, which was significantly higher than that observed in patients with CD. The sensitivity of parallelly combined detection of tuberculosis protein MPT64 and Xpert MTB/RIF in diagnosing ITB was 50.0%.
CONCLUSIONS: The detection of Xpert MTB/RIF in intestinal tissue is a rapid and useful method for establishing an early diagnosis of ITB. The detection of MTBC using Xpert MTB/RIF and MPT64 antigen in intestinal tissues has a definitive value in the differential diagnosis ofITB and CD. The combination of these two methods can improve the detection sensitivity.

Entities:  

Keywords:  Antigen; Crohn’s disease; Diagnosis; Intestinal tuberculosis; Xpert MTB/RIF

Year:  2021        PMID: 34049506     DOI: 10.1186/s12879-021-06210-8

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  23 in total

1.  European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

Authors:  S P L Travis; E F Stange; M Lémann; T Oresland; Y Chowers; A Forbes; G D'Haens; G Kitis; A Cortot; C Prantera; P Marteau; J-F Colombel; P Gionchetti; Y Bouhnik; E Tiret; J Kroesen; M Starlinger; N J Mortensen
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

2.  The clinical utility of cycle of threshold value of GeneXpert MTB/RIF (CBNAAT) and its diagnostic accuracy in pulmonary and extra-pulmonary samples at a tertiary care center in India.

Authors:  Ashish K Prakash; B Datta; J P Tripathy; N Kumar; P Chatterjee; A Jaiswal
Journal:  Indian J Tuberc       Date:  2018-06-08

3.  Performance of real-time PCR Xpert ®MTB/RIF in diagnosing extrapulmonary tuberculosis.

Authors:  Ester Mazzola; Marco Arosio; Alice Nava; Diana Fanti; Giovanni Gesu; Claudio Farina
Journal:  Infez Med       Date:  2016-12-01

4.  Analysis of colonoscopic findings in the differential diagnosis between intestinal tuberculosis and Crohn's disease.

Authors:  Y J Lee; S-K Yang; J-S Byeon; S-J Myung; H-S Chang; S-S Hong; K-J Kim; G H Lee; H-Y Jung; W-S Hong; J-H Kim; Y I Min; S J Chang; C S Yu
Journal:  Endoscopy       Date:  2006-04-27       Impact factor: 10.093

5.  Fullerene-doped polyaniline as new redox nanoprobe and catalyst in electrochemical aptasensor for ultrasensitive detection of Mycobacterium tuberculosis MPT64 antigen in human serum.

Authors:  Lijuan Bai; Yuhan Chen; Yan Bai; Yongjie Chen; Jing Zhou; Ailong Huang
Journal:  Biomaterials       Date:  2017-04-12       Impact factor: 12.479

Review 6.  Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.

Authors:  Mikashmi Kohli; Ian Schiller; Nandini Dendukuri; Keertan Dheda; Claudia M Denkinger; Samuel G Schumacher; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2018-08-27

7.  Detection of Tuberculosis in HIV Co-infected Individuals: Use of Multiple ELISA Responses to 38kDa, Lipoarabinomannan and ESAT- 6 of M. tuberculosis.

Authors:  Ravi Gutlapalli; Aparna Sykam; Sandeep P Tenali; Priscilla Chandran; Sujai Suneetha; Lavanya M Suneetha
Journal:  J Clin Diagn Res       Date:  2016-02-01

Review 8.  Global Epidemiology of Tuberculosis.

Authors:  Philippe Glaziou; Katherine Floyd; Mario C Raviglione
Journal:  Semin Respir Crit Care Med       Date:  2018-08-02       Impact factor: 3.119

9.  Temporal trends in the misdiagnosis rates between Crohn's disease and intestinal tuberculosis.

Authors:  Hyungil Seo; Seohyun Lee; Hoonsub So; Donghoi Kim; Seon-Ok Kim; Jae Seung Soh; Jung Ho Bae; Sun-Ho Lee; Sung Wook Hwang; Sang Hyoung Park; Dong-Hoon Yang; Kyung-Jo Kim; Jeong-Sik Byeon; Seung-Jae Myung; Suk-Kyun Yang; Byong Duk Ye
Journal:  World J Gastroenterol       Date:  2017-09-14       Impact factor: 5.742

Review 10.  Differentiating Crohn's disease from intestinal tuberculosis.

Authors:  Saurabh Kedia; Prasenjit Das; Kumble Seetharama Madhusudhan; Siddhartha Dattagupta; Raju Sharma; Peush Sahni; Govind Makharia; Vineet Ahuja
Journal:  World J Gastroenterol       Date:  2019-01-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.